Who we are
About us
Launched in September 2024 and funded by the UK charity LifeArc, we are a bold UK-wide initiative working to accelerate diagnosis and develop new treatments for patients with rare respiratory diseases.
Our partnership brings together UK universities, patient organisations, NHS trusts, and UKRI-funded non-profits.
Organisations
University of Cambridge
University of Dundee
University of Edinburgh
University of Nottingham
University of Southampton
University College London
Patient organisations
UKRI
Nucleic Acid Therapy Accelerator (NATA)
NATA is a UK research initiative helping to develop new RNA and DNA-based treatments. It supports our Centre by offering cutting-edge expertise that could lead to new therapies for rare respiratory diseases where few options currently exist.